2017
DOI: 10.1186/s12964-017-0203-0
|View full text |Cite
|
Sign up to set email alerts
|

Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure

Abstract: BackgroundOne of the most common side effects of the immunosuppressive drug tacrolimus (FK506) is the increased risk of new-onset diabetes mellitus. However, the molecular mechanisms underlying this association have not been fully clarified.MethodsWe studied the effects of the therapeutic dose of tacrolimus on mitochondrial fitness in beta-cells.ResultsWe demonstrate that tacrolimus impairs glucose-stimulated insulin secretion (GSIS) in beta-cells through a previously unidentified mechanism. Indeed, tacrolimus… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(29 citation statements)
references
References 59 publications
0
29
0
Order By: Relevance
“…It is also important to note the important role that pancreatic β cell mitochondria play in facilitating insulin secretion and that mitochondrial dysfunction in β cells is associated with beta cell failure and thus dysregulation of glucagon ( 94 96 ). This principle has been further substantiated recently in a study illustrating the deleterious effect of tacrolimus on β cell mitochondria and subsequent β cell failure ( 97 ). It is interesting to speculate that the mitochondrial impairment noted in aging and diabetes could deleteriously impact the metabolic flexibility needed for the mitochondria to adapt to an exercise challenge and further interfere with the acute adaptive response of the islet to an exercise bout.…”
Section: Pancreatic Dysfunctionmentioning
confidence: 81%
“…It is also important to note the important role that pancreatic β cell mitochondria play in facilitating insulin secretion and that mitochondrial dysfunction in β cells is associated with beta cell failure and thus dysregulation of glucagon ( 94 96 ). This principle has been further substantiated recently in a study illustrating the deleterious effect of tacrolimus on β cell mitochondria and subsequent β cell failure ( 97 ). It is interesting to speculate that the mitochondrial impairment noted in aging and diabetes could deleteriously impact the metabolic flexibility needed for the mitochondria to adapt to an exercise challenge and further interfere with the acute adaptive response of the islet to an exercise bout.…”
Section: Pancreatic Dysfunctionmentioning
confidence: 81%
“…Calstabin1 and calstabin2 preferentially bind RyR1 and RyR2, respectively, and help to stabilize the closed state of the channel (Santulli and Marks 2015). Calstabins are the cytosolic targets for the immunosuppressant drugs rapamycin and FK506 (Lombardi et al 2017a, 2017b). Rapamycin (or sirolimus) coated on coronary artery stents is used to prevent restenosis by inhibiting vascular smooth muscle migration and proliferation (Santulli 2015; Marks 2003; Santulli and Totary-Jain 2013; Santulli et al 2014).…”
Section: 7 Modulation Of Ryr Dynamics and Gatingmentioning
confidence: 99%
“…The calcineurin inhibitors, particularly tacrolimus, are commonly used as part of the immunosuppressive regimen post lung transplantation 47 48. Tacrolimus alters mitochondrial calcium uptake and uncouples oxidative phosphorylation 49–51. The combination of altered mitochondrial function secondary to the downregulated CFTR protein and the effect of calcineurin inhibitors on an organ with high oxidative demands such as the brain, could explain the increased neurological events in these patients.…”
Section: Discussionmentioning
confidence: 99%